Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
Abstract
The adenosine receptor system, which mediates the psychoactive effects of caffeine, is also thought to be involved in the regulation of anxiety. In this study, we examined the association between variations in anxiogenic responses to caffeine and polymorphisms in the A1 and A2a adenosine receptor genes. Healthy, infrequent caffeine users (N=94) recorded their subjective mood states following a 150 mg oral dose of caffeine freebase or placebo in a double-blind study. We found a significant association between self-reported anxiety after caffeine administration and two linked polymorphisms on the A2a receptor gene, the 1976C>T and 2592C>Tins polymorphisms. Individuals with the 1976T/T and the 2592Tins/Tins genotypes reported greater increases in anxiety after caffeine administration than the other genotypic groups. The study shows that an adenosine receptor gene polymorphism that has been associated with Panic Disorder is also associated with anxiogenic responses to an acute dose of caffeine.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Common variants of the gene encoding for the A2a receptor can disrupt sleep or cause anxiety in some individuals after ingesting caffeine.
“For example, common variants of the gene encoding for the A2a receptor can disrupt sleep (51) or cause anxiety in some individuals (52) after ingesting caffeine.”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [52]
Cites
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,527 · see citing works
The Measurement and Appraisal of Adult Intelligence (4th ed.).
Wechsler, D. (1958) · doi:10.1037/11167-000 · Cited by 1,683 · see citing works
A Shortened Version of the Profile of Mood States
Shacham, S. (1983) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4703_14 · Cited by 1,231 · cited 7× · see citing works
“Genetic variation in caffeine-induced anxiety K Alsene et al segment overlap at a pairwise score cutoff of 60.”
BackgroundInfluentialA workbench for multiple alignment construction and analysis
Schuler, G. D., Altschul, S. F., & Lipman, D. J. (1991) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340090304 · Cited by 985 · see citing works
Martin, W. R., Sloan, J. W., SAPIRA, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 945 · see citing works
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C. A., Vaugeois, J., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J. J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918 · see citing works
Structure and function of adenosine receptors and their genes
Fredholm, B. B., Arslan, G., Halldner, L., Kull, B., Schulte, G., & Wasserman, W. W. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000313 · Cited by 583 · see citing works
Research advances in alcohol and drug problems
Stephenson, J. P. (1975) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(75)90081-1 · Cited by 575 · see citing works
Johansson, B. A., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez‐Llort, L., Escorihuela, R. M., Fernández‐Teruel, A., Wiesenfeld‐Hallin, Z., Xu, X.-J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161292398 · Cited by 506 · see citing works
Increased Anxiogenic Effects of Caffeine in Panic Disorders
Charney, D. S. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260027003 · Cited by 428 · see citing works
The effects of low doses of caffeine on human performance and mood
Lieberman, H. R., Wurtman, R. J., Emde, G. G., Roberts, C., & Coviella, I. L. G. (1987) · Psychopharmacology · doi:10.1007/bf00210835 · Cited by 413 · see citing works
Dose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans
Kaplan, G. B., Greenblatt, D. J., Ehrenberg, B. L., Goddard, J. E., Cotreau, M. M., Harmatz, J. S., & Shader, R. I. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04356.x · Cited by 387 · see citing works
Caffeine - Its Identity, Dietary Sources, Intake and Biological Effects
Graham, D. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1978.tb03717.x · Cited by 317 · see citing works
Soussi, T., Dehouche, K., & Béroud, C. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 269 · see citing works
Goldstein, A., Kaizer, S., & Whitby, O. (1969) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1969104489 · Cited by 202 · see citing works
Increased Sensitivity to Caffeine in Patients With Panic Disorders
Boulenger, J. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220057009 · Cited by 193 · see citing works
Svenningsson, P., Nomikos, G. G., Ongini, E., & Fredholm, B. B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00046-8 · Cited by 170 · see citing works
Effects of caffeine on mood and memory
Loke, W. H. (1988) · Physiology & Behavior · doi:10.1016/0031-9384(88)90039-x · Cited by 163 · see citing works
Deckert, J., Nöthen, M. M., Franke, P. E., Delmo, C. D., Fritze, J., Knapp, M., Maier, W., Beckmann, H., & Propping, P. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000345 · Cited by 162 · see citing works
Caffeine Intake, Tolerance, and Withdrawal in Women: A Population-Based Twin Study
Kendler, K. S., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.223 · Cited by 125 · see citing works
Snyder, S. H., & Sklar, P. B. (1984) · Journal of Psychiatric Research · doi:10.1016/0022-3956(84)90001-3 · Cited by 124 · see citing works
Enhanced drug metabolism in cigarette smokers.
Hart, P. H., Farrell, G. C., Cooksley, W. G. E., & Powell, L. W. (1976) · BMJ · doi:10.1136/bmj.2.6028.147 · Cited by 123 · see citing works
Discriminative stimulus and subjective effects of theobromine and caffeine in humans
Mumford, G. K., Evans, S. M., Kaminski, B. J., Preston, K. L., Sannerud, C. A., Silverman, K., & Griffiths, R. R. (1994) · Psychopharmacology · doi:10.1007/bf02244744 · Cited by 117 · see citing works
Reinforcing properties of caffeine: Studies in humans and laboratory animals
Griffiths, R. R., & Woodson, P. P. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90180-3 · Cited by 113 · see citing works
Correlation of intrinsic DNA curvature with DNA property periodicity
Gabrielian, A. E., & Pongor, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00855-1 · Cited by 103 · see citing works
Caffeine: relationship to human anxiety, plasma MHPG and cortisol.
Uhde, T. W., Boulenger, J.-P., Jimerson, D. C., & Post, R. M. (1984) · PubMed · Cited by 96 · see citing works
Anxiety and Muscle Tension as Consequences of Caffeine Withdrawal
White, B. C., Lincoln, C., Pearce, N. W., Reeb, R., & Vaida, C. (1980) · Science · doi:10.1126/science.7433978 · Cited by 77 · see citing works
Anxiogenic effects of caffeine on panic and depressed patients
Lee, M. A., Flegel, P., Greden, J. F., & Cameron, O. G. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.632 · Cited by 75 · see citing works
Eysenck, S. B. G. (1993) · American Psychological Association eBooks · doi:10.1037/10500-009 · Cited by 74 · see citing works
Mood effects of diazepam and caffeine
Svensson, E., Persson, L., & Sj�berg, L. (1980) · Psychopharmacology · doi:10.1007/bf00427598 · Cited by 61 · see citing works
Kamimori, G. H., Joubert, A., Otterstetter, R., Santaromana, M., & Eddington, N. D. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050654 · Cited by 49 · see citing works
Yamada, K., Hattori, E., Shimizu, M., Sugaya, A., Shibuya, H., & Yoshikawa, T. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170033 · Cited by 48 · see citing works
Griffiths, R. R., & Mumford, G. K. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_9 · Cited by 48 · see citing works
A translation repressor element resides in the 3′ untranslated region of human p53 mRNA
Fu, L., Ma, W., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203064 · Cited by 46 · see citing works
Deckert, J., Nöthen, M. M., Rietschel, M., Wildenauer, D. B., Bondy, B., Ertl, M. A., Knapp, M., Schofield, P. R., Albus, M., Maier, W., et al. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271259 · Cited by 42 · see citing works
Dose-related caffeine discrimination in normal volunteers
Evans, S., & Griffiths, R. R. (1991) · Behavioural Pharmacology · doi:10.1097/00008877-199109000-00011 · Cited by 41 · see citing works
Known and Hidden Sources of Caffeine in Drug, Food, and Natural Products
Durrant, K. (2002) · Journal of the American Pharmaceutical Association (1996) · doi:10.1331/108658002763029607 · Cited by 37 · see citing works
Factors influencing the subjective response to caffeine
Chait, L. D. (1992) · Behavioural Pharmacology · doi:10.1097/00008877-199206000-00005 · Cited by 31 · see citing works
Comparison of amphetamine sulphate and caffeine citrate in man
LADER, M. H. (1969) · Psychopharmacology · doi:10.1007/bf00403681 · Cited by 31 · see citing works
Pharmacological Aspects of Drug Dependence
Schuster, C. R., & Kuhar, M. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3 · Cited by 31 · see citing works
Zubenko, G. S., Stiffler, J. S., Hughes, H. B., Hurtt, M. R., & Kaplan, B. B. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980207)81:1 · Cited by 29 · see citing works
Curved DNA without AA/TT dinucleotide step
Brukner, I. B., Jurukovski, V., Konstantinović, M. M., & Savić, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.13.3549 · Cited by 20 · see citing works
Subjective effects of caffeine among introverts and extraverts in the morning and evening.
Liguori, A., Grass, J. A., & Hughes, J. R. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.7.3.244 · Cited by 19 · see citing works
Effects of caffeine on recognition
Gupta, U. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90480-h · Cited by 13 · see citing works
EFFECTS OF CAFFEINE ON PERFORMANCE OF LOW INTENSITY TASKS
Scott, W. H., Coyne, K. M., Johnson, M. M., Lausted, C. G., Sahota, M. S., & Johnson, A. T. (2002) · Perceptual and Motor Skills · doi:10.2466/pms.2002.94.2.521 · Cited by 13 · see citing works
Effects of Caffeine on Perceptual Judgment
Gupta, U., Dubey, G. P., & Gupta, B. S. (2008) · Neuropsychobiology · doi:10.1159/000119159 · Cited by 8 · see citing works
Song, X., & Singh, S. M. (2001) · DNA and Cell Biology · doi:10.1089/10445490152122451 · Cited by 1 · see citing works
Factor structure of the Barratt impulsiveness scale
Patton, J. H., Stanford, M. S., & Barratt, E. S. (1995) · Journal of Clinical Psychology · doi:10.1002/1097-4679(199511)51:6
Flagged first, then by citations
2 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Fifty years of the Barratt Impulsiveness Scale: an update and review
Stanford, M. S., Mathias, C. W., Dougherty, D. M., Lake, S. L., Anderson, N. E., & Patton, J. H. (2009) · Personality and Individual Differences · doi:10.1016/j.paid.2009.04.008 · Cited by 1,609 · see citing works
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J. M., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,307 · see citing works
<i>Sleep Deprivation and Vigilant Attention</i>
Lim, J., & Dinges, D. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.002 · Cited by 1,213 · see citing works
Caffeinated energy drinks a growing problem
Reissig, C. J., Strain, E. C., & Griffiths, R. R. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.001 · Cited by 1,026 · see citing works
Adenosine receptors as drug targets — what are the challenges?
Chen, J., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 899 · see citing works
Fredholm, B. B., Chen, J., Cunha, R. A., Svenningsson, P., & Vaugeois, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 694 · see citing works
International society of sports nutrition position stand: caffeine and performance
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby, D., Stout, J., Graves, B. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-5 · Cited by 686 · see citing works
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665 · see citing works
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632 · see citing works
Scientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4102 · Cited by 613 · see citing works
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 585 · see citing works
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1379 · Cited by 584 · see citing works
The Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557 · see citing works
Clark, I., & Landolt, H. P. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.01.006 · Cited by 499 · see citing works
Comorbidity of insomnia and depression
Staner, L. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.09.003 · Cited by 481 · see citing works
The Effect of Exercise Training on Anxiety Symptoms Among Patients: A Systematic Review
Herring, M. P. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.530 · Cited by 446 · see citing works
Wikoff, D. S., Welsh, B. T., Henderson, R. G., Brorby, G. P., Britt, J. K., Myers, E. F., Goldberger, J. J., Lieberman, H. R., O’Brien, C. P., Peck, J. D., et al. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.04.002 · Cited by 451 · see citing works
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419 · see citing works
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illés, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 394 · see citing works
ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and Drugs
Fredholm, B. B., Chen, J., Masino, S. A., & Vaugeois, J. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095731 · Cited by 354 · see citing works
Caffeine use in children: What we know, what we have left to learn, and why we should worry
Temple, J. L. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.001 · Cited by 328 · see citing works
Genetics of caffeine consumption and responses to caffeine
Yang, A., Palmer, A. A., & de Wit, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1900-1 · Cited by 310 · see citing works
Rétey, J. V., Adam, M., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H.-P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100102 · Cited by 278 · see citing works
Adenosine Receptors and the Central Nervous System
Sebastião, A. M., & Ribeiro, J. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_16 · Cited by 271 · see citing works
Hayes, J. E., Wallace, M. R., Knopik, V. S., Herbstman, D. M., Bartoshuk, L. M., & Duffy, V. B. (2010) · Chemical Senses · doi:10.1093/chemse/bjq132 · Cited by 261 · see citing works
Rétey, J., Adam, M., Honegger, E., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505414102 · Cited by 260 · see citing works
Roy‐Byrne, P., Craske, M. G., & Stein, M. B. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69418-x · Cited by 261 · see citing works
Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. A., & de Wit, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.17 · Cited by 252 · see citing works
Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation
James, J. E., & Rogers, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0084-6 · Cited by 231 · see citing works
Caffeine, Mental Health, and Psychiatric Disorders
Lara, D. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1378 · Cited by 236 · see citing works
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1408 · Cited by 233 · see citing works
Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption
Cornelis, M. C., El‐Sohemy, A., & Campos, H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.240 · Cited by 231 · see citing works
The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?
Addicott, M. A., Yang, L. L., Peiffer, A. M., Burnett, L. R., Burdette, J. H., Chen, M. Y., Hayasaka, S., Kraft, R. A., Maldjian, J. A., & Laurienti, P. J. (2009) · Human Brain Mapping · doi:10.1002/hbm.20732 · Cited by 210 · see citing works
Rogers, P. J., Hohoff, C., Heatherley, S. V., Mullings, E. L., Maxfield, P. J., Evershed, R. P., Deckert, J., & Nutt, D. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.71 · Cited by 212 · see citing works
Self-citationCaffeine Use Disorder: A Comprehensive Review and Research Agenda
Meredith, S. E., Juliano, L. M., Hughes, J. R., & Griffiths, R. R. (2013) · Journal of Caffeine Research · doi:10.1089/jcr.2013.0016 · Cited by 210 · see citing works
Pickering, C., & Kiely, J. (2017) · Sports Medicine · doi:10.1007/s40279-017-0776-1 · Cited by 221 · see citing works
Caffeine and the dopaminergic system
Cauli, O., & Morelli, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00001 · Cited by 196 · see citing works
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Cunha, R. A., Ferré, S., Vaugeois, J., & Chen, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480090 · Cited by 187 · see citing works
Monteiro, J., Alves, M. G., Oliveira, P. F., & Silva, B. M. (2016) · Molecules · doi:10.3390/molecules21080974 · Cited by 189 · see citing works
Adenosine, caffeine, and sleep–wake regulation: state of the science and perspectives
Reichert, C. F., Deboer, T., & Landolt, H. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13597 · Cited by 183 · see citing works
“Moreover, healthy people with polymorphisms in the ADORA2A gene exhibit elevated risk of anxiety symptoms when consuming normal amounts of caffeine-containing products (Alsene et al., 2003).”
BackgroundRogers, P. J., Smith, J. E., Heatherley, S. V., & Pleydell-Pearce, C. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0938-1 · Cited by 179 · see citing works
Do initial responses to drugs predict future use or abuse?
de Wit, H., & Phillips, T. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.04.005 · Cited by 172 · see citing works
Gonçalves, L. D. S., Painelli, V. D. S., Yamaguchi, G., Oliveira, L. F. D., Saunders, B., da Silva, R. P., Maciel, E., Artioli, G. G., Roschel, H., & Gualano, B. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00260.2017 · Cited by 173 · see citing works
Caffeine and Exercise: What Next?
Pickering, C., & Grgić, J. (2019) · Sports Medicine · doi:10.1007/s40279-019-01101-0 · Cited by 178 · see citing works
Bandelow, B., Baldwin, D. S., Abelli, M., Altamura, C. A., Dell’Osso, B. M., Domschke, K., Fineberg, N. A., Grünblatt, E., Jarema, M., Maron, E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1181783 · Cited by 165 · see citing works
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
IJzerman, A. P., Jacobson, K. A., Müller, C. E., Cronstein, B. N., & Cunha, R. A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000445 · Cited by 163 · see citing works
The effect of caffeine on energy balance
Harpaz, E., Tamir, S., Weinstein, A., & Weinstein, Y. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0090 · Cited by 160 · see citing works
Ullrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145 · see citing works
Wei, C. J., Li, W., & Chen, J. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.018 · Cited by 151 · see citing works
Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder
Hamilton, S. P., Slager, S. L., Baisre, A., Heiman, G. A., Klein, D. F., Hodge, S. E., Weissman, M. M., Fyer, A. J., & Knowles, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300311 · Cited by 147 · see citing works
The role of adenosine receptors in mood and anxiety disorders
van Calker, D., Biber, K. P. H., Domschke, K., & Serchov, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14841 · Cited by 142 · see citing works
Mitchell, E. S., Slettenaar, M., Meer, N. V., Transler, C., Jans, L. A. W., Quadt, F., & Berry, M. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.07.027 · Cited by 127 · see citing works
Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Ortiz, R., Ulrich, H., Zarate, C. A., & Machado‐Vieira, R. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.10.016 · Cited by 126 · see citing works
Thorn, C. F., Aklillu, E., McDonagh, E. M., Klein, T. E., & Altman, R. B. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283505d5e · Cited by 125 · see citing works
Imaging genetics of anxiety disorders
Domschke, K., & Dannlowski, U. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.042 · Cited by 122 · see citing works
Neuropsychiatric effects of caffeine
Winston, A. P., Hardwick, E., & Jaberi, N. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.6.432 · Cited by 120 · see citing works
Adenosine receptor neurobiology: overview
Chen, J.-F., Lee, C.-F., & Chern, Y. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00001-5 · Cited by 119 · see citing works
Rétey, J., Adam, M., Gottselig, J. M., Khatami, R., Dürr, R., Achermann, P., & Landolt, H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1538-06.2006 · Cited by 119 · see citing works
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease
Popat, R. A., Eeden, S. K. V. D., Tanner, C. M., Kamel, F., Umbach, D. M., Marder, K. S., Mayeux, R. P., Ritz, B. R., Ross, G. W., Petrovitch, H., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03353.x · Cited by 119 · see citing works
Bodenmann, S., Hohoff, C., Freitag, C. M., Deckert, J., Rétey, J., Bachmann, V., & Landolt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01689.x · Cited by 118 · see citing works
Life events in panic disorder-an update on “candidate stressors”
Klauke, B., Deckert, J., Reif, A., Pauli, P., & Domschke, K. (2010) · Depression and Anxiety · doi:10.1002/da.20667 · Cited by 117 · see citing works
Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences
Adan, A., Prat, G., Fabbri, M., & Sànchez-Turet, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.005 · Cited by 113 · see citing works
Adenosine, Caffeine, and Performance: From Cognitive Neuroscience of Sleep to Sleep Pharmacogenetics
Urry, E., & Landolt, H. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_274 · Cited by 108 · see citing works
Advances in molecular genetics of panic disorder
Maron, E., Hettema, J. M., & Shlik, J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.145 · Cited by 106 · see citing works
Martin, V. T., & Vij, B. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12953 · Cited by 107 · see citing works
Psychopharmacology of theobromine in healthy volunteers
Baggott, M. J., Childs, E., Hart, A. B., de Bruin, E. A., Palmer, A. A., Wilkinson, J. E., & de Wit, H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3021-0 · Cited by 106 · see citing works
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
Coelho, J. E., Alves, P., Canas, P. M., Valadas, J. S., Shmidt, T., Batalha, V. L., Ferreira, D. G., Ribeiro, J. A., Bader, M., Cunha, R. A., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00067 · Cited by 102 · see citing works
Hohoff, C., Mullings, E. L., Heatherley, S. V., Freitag, C. M., Neumann, L. C., Domschke, K., Krakowitzky, P., Rothermundt, M., Keck, M. E., Erhardt, A., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.006 · Cited by 102 · see citing works
Low, but not high, dose caffeine is a readily available probe for adenosine actions
Fredholm, B. B., Yang, J., & Wang, Y.-Q. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.11.011 · Cited by 99 · see citing works
Pharmacological potential of methylxanthines: Retrospective analysis and future expectations
Monteiro, J., Alves, M. G., Oliveira, P. F., & Silva, B. M. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1461607 · Cited by 103 · see citing works
Prediger, R. D., Silva, G. E. D., Batista, L. C., Bittencourt, A. L., & Takahashi, R. N. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301001 · Cited by 97 · see citing works
Haskell‐Ramsay, C. F., Jackson, P. A., Forster, J. S., Dodd, F. L., Bowerbank, S. L., & Kennedy, D. O. (2018) · Nutrients · doi:10.3390/nu10101386 · Cited by 97 · see citing works
Multi-ingredient, Caffeine-containing Dietary Supplements: History, Safety, and Efficacy
Gurley, B. J., Steelman, S. C., & Thomas, S. L. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.08.012 · Cited by 96 · see citing works
Involvement of Adenosine A2A Receptors in Depression and Anxiety
Yamada, K., Kobayashi, M., & Kanda, T. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00015-5 · Cited by 93 · see citing works
The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective
Rao, T., Tan, Z., Peng, J., Guo, Y., Chen, Y., Zhou, H., & Ouyang, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104283 · Cited by 92 · see citing works
Lazarus, M., Chen, J., Huang, Z., Urade, Y., & Fredholm, B. B. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_36 · Cited by 93 · see citing works
Wilk, M., Krzysztofik, M., Filip, A., Zając, A., & Coso, J. D. (2019) · Nutrients · doi:10.3390/nu11081912 · Cited by 80 · see citing works
Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A., & Welsh, B. T. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033243 · Cited by 87 · see citing works
Adenosine and related drugs in brain diseases: present and future in clinical trials.
Lopes, L. V., Sebastião, A., & Ribeiro, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347591 · Cited by 94 · see citing works
Caffeine and Exercise Performance: Possible Directions for Definitive Findings
Martins, G. L., Guilherme, J. P. L. F., Ferreira, L. H. B., de Souza, T. P., & Lancha, A. H. (2020) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2020.574854 · Cited by 90 · see citing works
Salinero, J. J., Lara, B., Ruiz-Vicente, D., Areces, F., Puente, C., Gallo–Salazar, C., Pascual, T., & Coso, J. D. (2017) · Nutrients · doi:10.3390/nu9030269 · Cited by 82 · see citing works
The Role of Genetics in Moderating the Inter-Individual Differences in the Ergogenicity of Caffeine
Southward, K., Rutherfurd-Markwick, K., Badenhorst, C., & Ali, A. (2018) · Nutrients · doi:10.3390/nu10101352 · Cited by 81 · see citing works
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
Dhaenens, C., Burnouf, S., Simonin, C., Brussel, E. V., Duhamel, A., Defebvre, L., Duru, C., Vuillaume, I., Cazeneuve, C., Charles, P., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.009 · Cited by 80 · see citing works
Freitag, C. M., Agelopoulos, K., Huy, E., Rothermundt, M., Krakowitzky, P., Meyer, J., Deckert, J., von Gontard, A., & Hohoff, C. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0043-6 · Cited by 77 · see citing works
ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus
Shinohara, M., Saitoh, M., Nishizawa, D., Ikeda, K., Hirose, S., Takanashi, J., Takita, J., Kikuchi, K., Kubota, M., Yamanaka, G., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f18d8 · Cited by 75 · see citing works
Arnold, P. D., Zai, G. C., & Richter, M. A. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0073-1 · Cited by 74 · see citing works
Kennedy, D. O., & Haskell, C. F. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2010.12.010 · Cited by 73 · see citing works
Adenosine A 1 , but not A 2 , Receptor Blockade Increases Anxiety and Arousal in Zebrafish
Maximino, C., Lima, M. G., Olivera, K. R. M., Picanço-Diniz, D. L. W., & Herculano, A. M. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00710.x · Cited by 73 · see citing works
Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review
Fulton, J. L., Dinas, P. C., Carrillo, A. E., Edsall, J. R., Ryan, E. J., & Ryan, E. J. (2018) · Nutrients · doi:10.3390/nu10101373 · Cited by 70 · see citing works
Sharma, S., Das, M., Kumar, A., Marwaha, V., Shankar, S., Singh, P., Raghu, P., Aneja, R., Grover, R., Arya, V., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328331b53e · Cited by 69 · see citing works
Genetic determinants of blood pressure responses to caffeine drinking
Renda, G., Zimarino, M., Antonucci, I., Tatasciore, A., Ruggieri, B., Bucciarelli, T., Prontera, T., Stuppia, L., & Caterina, R. D. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018267 · Cited by 69 · see citing works
Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
Domenici, M. R., Ferrante, A., Martire, A., Chiodi, V., Pepponi, R., Tebano, M. T., & Popoli, P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104338 · Cited by 70 · see citing works
The type 1 equilibrative nucleoside transporter regulates anxiety‐like behavior in mice
Chen, J., Rinaldo, L., Lim, S. ‐., Young, H., Messing, R. O., & Choi, D. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00311.x · Cited by 68 · see citing works
Genetic determination of sleep EEG profiles in healthy humans
Landolt, H.-P. (2011) · Progress in Brain Research · doi:10.1016/b978-0-444-53839-0.00004-1 · Cited by 67 · see citing works
Blood Pressure in Relation to Coffee and Caffeine Consumption
Guessous, I., Eap, C. B., & Bochud, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0468-2 · Cited by 67 · see citing works
Caffeine intake and anxiety: a meta-analysis
Liu, C., Wang, L., Zhang, C., Hu, Z., Tang, J., Xue, J., & Lu, W. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1270246 · Cited by 80 · see citing works
Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition
Shen, H., & Chen, J. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152191 · Cited by 66 · see citing works
Klevebrant, L., & Frick, A. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2021.11.005 · Cited by 63 · see citing works
Genotype-Dependent Differences in Sleep, Vigilance, and Response to Stimulants
Landolt, H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549344 · Cited by 63 · see citing works
Storm in a coffee cup: caffeine modifies brain activation to social signals of threat
Smith, J. E., Lawrence, A. D., Diukova, A., Wise, R. G., & Rogers, P. J. (2011) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsr058 · Cited by 62 · see citing works
- Authors
- Alsene, K., Deckert, J., Sand, P., & de Wit, H.
- Affiliations
- University of Chicago (US)
- University of Münster (DE)
- University of Würzburg (DE)
- Venue
- Neuropsychopharmacology
- Published
- 2003-05-14
- Volume
- 28
- Issue
- 9
- Pages
- 1694-1702
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2043153453
- Cited by
- 334
- References
- 50
- Citations by year
- 2026: 12 · 2025: 6 · 2024: 10 · 2023: 12 · 2022: 8 · 2021: 13 · 2020: 13 · 2019: 18 · 2018: 18 · 2017: 16 · 2016: 19 · 2015: 9 · 2014: 21 · 2013: 11 · 2012: 21
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 02812, R01DA002812)
- Topics
- Health Sciences › Medicine › Pharmacology › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Keywords
- caffeine, anxiety, adenosine A2A receptor, adenosine A1 receptor, genetic polymorphism, subjective mood, panic disorder, genetic susceptibility
- MeSH terms
- Adult, Central Nervous System Stimulants, Animals, Anxiety, Caffeine, Cysteine, Double-Blind Method, Female, Genotype, Humans, Hybrid Vigor, Male, Neuropsychological Tests, Pain Measurement, Personality Inventory, Polymorphism, Genetic, Threonine, Time Factors, Genetic Variation, Sequence Analysis, DNA, Receptors, Purinergic P1, Tandem Repeat Sequences, Receptor, Adenosine A2A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review